10232017Headline:

Honolulu, Hawaii

HomeHawaiiHonolulu

Email Wayne Parsons Wayne Parsons on LinkedIn Wayne Parsons on Facebook
Wayne Parsons
Wayne Parsons
Attorney • (808) 845-2211

Glaxo tests Tykerb versus Herceptin for early Breast Cancer Treatment

Comments Off

GlaxoSmithKline has begun a phase III clinical study that will compare comparing its drug Tykerb with Herceptin in the treatment of early breast cancer. The trial will measure which cancer cells disappear in the breast following treatment with Tykerb and/or Herceptin before surgery in women with early-stage breast cancer whose tumours overexpress the HER2 protein.